http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014020381-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43daf89bdce4fa9b10dbc1e339f57bd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd10b5305cfe37e61370b46240c5d976
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8e189ccb472af96fe032b7b7eef62b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8c5fa5f189cb6a2e0da3733c346676e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05b5dd836c2d94d8c80b2204ee20335c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e475306d9c4018ef655d7b04a71fb7d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99a44a276d36ba6c1dcabcc898660738
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4245
filingDate 2012-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcf117f5ffa75df7dd6ff151f2eff816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e976396408532e9ad3ec28435b13eb74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92e6a435f5e10571057a56807502a765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f6243f0af9ecfea762b67b6d1f081e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_492b24797924e1606d0834c8f7540a37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d8a95c7f540b1ddf761437064bce47a
publicationDate 2014-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014020381-A1
titleOfInvention Novel crystalline form of azilsartan medoxomil potassium
abstract The present invention describes novel crystalline form AL of Azilsartan medoxomil potassium, process for their preparation and pharmaceutical compositions containing them.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105753854-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9403811-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109071519-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014364464-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017131218-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018087178-A
priorityDate 2012-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012107814-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013042067-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7157584-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012090043-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226529482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID172198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23669619
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397561
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135415867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414127

Total number of triples: 46.